Last reviewed · How we verify

NCT05828030

HFNC Compared With Facial Mask in Patients With Chest Trauma Patients

Recruiting now NA Last updated 8 September 2025
What this trial tests

NA trial testing high flow nasal cannula in Chest Trauma in 100 participants. Currently enrolling.

Timeline
26 April 2023
Primary endpoint
31 December 2026
31 December 2027

Quick facts

Lead sponsorNational Taiwan University Hospital
PhaseNA
StatusRecruiting now
Study typeINTERVENTIONAL
Allocationrandomized
Designparallel
Maskingnone
Primary purposetreatment
Enrollment100
Start date26 April 2023
Primary completion31 December 2026
Estimated completion31 December 2027
Sites2 locations across Taiwan

Drugs / interventions tested

Conditions studied

Sponsor

National Taiwan University Hospital

Who can join

Adults 20 to 99, any sex, with Chest Trauma or Hypoxia. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Guidelines for noninvasive ventilation (NIV) recommend continuous positive airway pressure in patients with thoracic trauma who remain hypoxic . However, no any suggestion was applied for high flow nasal cannula (HFNC). Therefore, Our aim was to determine whether HFNC reduces intubation in severe trauma-related hypoxemia.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other trials of high flow nasal cannula

Trials testing the same drug.

Other recruiting trials for Chest Trauma

Currently open trials in the same condition.

Other National Taiwan University Hospital trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05828030.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing